Guddi Singh, MB BChir, MPH, John Owens, MA, PhD, and Alan Cribb, PhD
Co-creation initiatives in health care have potential to support health equity but require a redistribution of power and a common vision in order to succeed.
AMA J Ethics. 2017; 19(11):1132-1138. doi:
10.1001/journalofethics.2017.19.11.msoc1-1711.
A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices.
AMA J Ethics. 2021; 23(9):E712-720. doi:
10.1001/amajethics.2021.712.
Iris G. Insogna, MD, MBE and Elizabeth S. Ginsburg, MD
Although the World Health Organization defines infertility as a disease, insurance coverage gaps generate disparities in access to care and treatment, especially for tubal factor infertility and oncofertility.
AMA J Ethics. 2018; 20(12):E1152-1159. doi:
10.1001/amajethics.2018.1152.
Professor Katie Watson joins Ethics Talk to consider key questions about clinical and legal risk management for clinicians trying keep patients safe and for patients with complex pregnancies trying to stay alive.
After years of funding disease-specific treatment, donation trends have shifted to support broader health systems infrastructure development. A remaining challenge is how to sustain antiretroviral therapy (ART) for patients in resource-poor regions.
AMA J Ethics. 2016; 18(7):681-690. doi:
10.1001/journalofethics.2016.18.7.ecas3-1607.